{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:25:38Z","timestamp":1789986338492,"version":"4.0.1"},"reference-count":345,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["192123"],"award-info":[{"award-number":["192123"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.vaccine.2025.127775","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T19:02:49Z","timestamp":1758826969000},"page":"127775","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Rationalizing recommendations for influenza and COVID-19 vaccines"],"prefix":"10.1016","volume":"65","author":[{"given":"Jessica A.","family":"Breznik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn M.E.","family":"Bowdish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127775_bb0005","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268825000317","article-title":"Comparison of two methods for the estimation of COVID-19 vaccine effectiveness of the autumnal booster within the VEBIS-EHR network in 2022\/23","volume":"153","author":"Monge","year":"2025","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2025.127775_bb0010","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1080\/1040841X.2019.1614904","article-title":"The role of viral infections in the development of autoimmune diseases","volume":"45","author":"Hussein","year":"2019","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.vaccine.2025.127775_bb0015","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41390-024-03145-z","article-title":"Viral infections in pregnancy and impact on offspring neurodevelopment: mechanisms and lessons learned","volume":"96","author":"Yates","year":"2024","journal-title":"Pediatr Res"},{"key":"10.1016\/j.vaccine.2025.127775_bb0020","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0140-6736(11)61577-8","article-title":"Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review","volume":"379","author":"Mwaniki","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.127775_bb0025","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1186\/s12889-023-16768-4","article-title":"The association of herpes zoster and influenza vaccinations with the risk of developing dementia: a population-based cohort study within the UK Clinical Practice Research Datalink","volume":"23","author":"Lophatananon","year":"2023","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2025.127775_bb0030","doi-asserted-by":"crossref","first-page":"5112","DOI":"10.1002\/jmv.27996","article-title":"The global impact of COVID-19 pandemic on the incidence of pediatric new-onset type 1 diabetes and ketoacidosis: a systematic review and meta-analysis","volume":"94","author":"Rahmati","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2025.127775_bb0035","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.21281","article-title":"Incidence of diabetes in children and adolescents during the COVID-19 pandemic: a systematic review and Meta-analysis","volume":"6","author":"D\u2019Souza","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2025.127775_bb0040","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.33014","article-title":"Association of SARS-CoV-2 infection with new-onset type 1 diabetes among pediatric patients from 2020 to 2021","volume":"5","author":"Kendall","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2025.127775_bb0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41574-024-01004-9","article-title":"The relationship between SARS-CoV-2 infection and type 1 diabetes mellitus","author":"Debuysschere","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.vaccine.2025.127775_bb0050","doi-asserted-by":"crossref","unstructured":"Mefford MT, Wei R, Lustigova E, Martin JP, Reynolds K. Incidence of diabetes among youth before and during the COVID-19 pandemic. JAMA Netw Open 2023;6:e2334953-e. doi: https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.34953.","DOI":"10.1001\/jamanetworkopen.2023.34953"},{"key":"10.1016\/j.vaccine.2025.127775_bb0055","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa2311330","article-title":"Cognition and memory after covid-19 in a large community sample","volume":"390","author":"Hampshire","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb0060","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1007\/s10067-023-06670-0","article-title":"Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study","volume":"42","author":"Tesch","year":"2023","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.vaccine.2025.127775_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101783","article-title":"Risk of autoimmune diseases in patients with COVID-19: a retrospective cohort study","volume":"56","author":"Chang","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.vaccine.2025.127775_bb0070","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.55599","article-title":"Hospital outcomes of community-acquired SARS-CoV-2 omicron variant infection compared with influenza infection in Switzerland","volume":"6","author":"Portmann","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2025.127775_bb0075","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1001\/jama.2023.5348","article-title":"Risk of death in patients hospitalized for COVID-19 vs seasonal influenza in Fall-Winter 2022-2023","volume":"329","author":"Xie","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2025.127775_bb0080","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1001\/jama.2024.7395","article-title":"Mortality in patients hospitalized for COVID-19 vs influenza in Fall-Winter 2023-2024","volume":"331","author":"Xie","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2025.127775_bb0085","article-title":"Excess respiratory hospitalisations associated with influenza, respiratory syncytial virus and SARS-CoV-2 in Singapore from 2015 to 2023","volume":"19","author":"Qi Chia","year":"2025","journal-title":"Influenza Other Respi Viruses"},{"key":"10.1016\/j.vaccine.2025.127775_bb0090","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/jamainternmed.2024.7452","article-title":"Severity and Long-term mortality of COVID-19, influenza, and respiratory syncytial virus","volume":"185","author":"Bajema","year":"2025","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb0095","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3201\/eid3103.240594","article-title":"Annual hospitalizations for COVID-19, influenza, and respiratory syncytial virus, United States, 2023\u20132024","volume":"31","author":"Bi","year":"2025","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb0100","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S1473-3099(24)00806-5","article-title":"The post-pandemic hospital and mortality burden of COVID-19 compared with influenza: a national cohort study in Denmark, May 2022 to June 2024","volume":"2024","author":"Bager","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106292","article-title":"Severity of respiratory syncytial virus compared with SARS-CoV-2 and influenza among hospitalised adults \u226565 years","volume":"89","author":"Vega-Piris","year":"2024","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2025.127775_bb0110","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/01410768231184162","article-title":"Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adults","volume":"116","author":"Hyams","year":"2023","journal-title":"J R Soc Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb0115","article-title":"The medical complexity of newly admitted long-term care residents before and during the COVID-19 pandemic in Ontario, British Columbia, and Alberta: a serial cross-sectional study","volume":"17","author":"Al-Sharkawi","year":"2024","journal-title":"Health Serv Insights"},{"key":"10.1016\/j.vaccine.2025.127775_bb0120","doi-asserted-by":"crossref","first-page":"90","DOI":"10.21037\/apm-22-858","article-title":"Need for inpatient rehabilitation and skilled nursing services in COVID-19 patients post hospitalization: a retrospective cohort study","volume":"12","author":"Kapur","year":"2023","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb0125","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/s41591-024-03173-6","article-title":"Long COVID science, research and policy","volume":"30","author":"Al-Aly","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb0130","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1016\/j.vaccine.2008.04.043","article-title":"Optimal allocation of pandemic influenza vaccine depends on age, risk and timing","volume":"26","author":"Mylius","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127775_bb0135","doi-asserted-by":"crossref","first-page":"365","DOI":"10.15585\/mmwr.mm7110a1","article-title":"Interim estimates of 2021-22 seasonal influenza vaccine effectiveness - United States, February 2022","volume":"71","author":"Chung","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2025.127775_bb0140","author":"U.S. Centers for Disease Control and Prevention"},{"key":"10.1016\/j.vaccine.2025.127775_bb0145","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/infdis\/jix282","article-title":"The importance of frailty in the assessment of influenza vaccine effectiveness against influenza-related hospitalization in elderly people","volume":"216","author":"Andrew","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb0150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2807\/1560-7917.ES.2017.22.44.17-00306","article-title":"End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016\/17","volume":"22","author":"Pebody","year":"2017","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2025.127775_bb0155","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/cid\/cis574","article-title":"Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains","volume":"55","author":"Treanor","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb0160","first-page":"20388","article-title":"Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011\/12","volume":"18","author":"Castilla","year":"2013","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2025.127775_bb0165","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.vaccine.2018.01.045","article-title":"Influenza vaccine effectiveness in older adults compared with younger adults over five seasons","volume":"36","author":"Russell","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127775_bb0170","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1016\/j.vaccine.2015.07.003","article-title":"Efficacy and immunogenicity of high-dose influenza vaccine in older adults by age, comorbidities, and frailty","volume":"33","author":"DiazGranados","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127775_bb0175","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1002\/pds.4298","article-title":"Controlling confounding by frailty when estimating influenza vaccine effectiveness using predictors of dependency in activities of daily living","volume":"26","author":"Zhang","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2025.127775_bb0180","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/irv.12486","article-title":"Annual estimates of the burden of seasonal influenza in the United States: a tool for strengthening influenza surveillance and preparedness","volume":"12","author":"Rolfes","year":"2018","journal-title":"Influenza Other Respi Viruses"},{"key":"10.1016\/j.vaccine.2025.127775_bb0185","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/cid\/ciw635","article-title":"2014\u20132015 influenza vaccine effectiveness in the United States by vaccine type","volume":"63","author":"Zimmerman","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb0190","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/infdis\/jiu647","article-title":"Influenza vaccine effectiveness in the United States during 2012\u20132013: variable protection by age and virus type","volume":"211","author":"McLean","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb0195","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/cid\/ciz075","article-title":"Effects of influenza vaccination in the United States during the 2017\u20132018 influenza season","volume":"69","author":"Rolfes","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb0200","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/cid\/cix468","article-title":"Influenza vaccination modifies disease severity among community-dwelling adults hospitalized with influenza","volume":"65","author":"Arriola","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb0205","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jama.2024.5633","article-title":"Test-negative study designs for evaluating vaccine effectiveness","volume":"332","author":"Dean","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2025.127775_bb0210","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.vaccine.2025.127775_bb0215","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaf124","article-title":"Annual variant-targeted vaccination to prevent severe COVID-19 disease in cohorts with vaccine-derived and hybrid immunity","author":"Kelly","year":"2025","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb0220","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S2213-2600(23)00306-5","article-title":"Effectiveness of BNT162b2 BA.4\/5 bivalent mRNA vaccine against a range of COVID-19 outcomes in a large health system in the USA: a test-negative case-control study","volume":"11","author":"Tartof","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb0225","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41591-022-02185-4","article-title":"A survey of COVID-19 vaccine acceptance across 23 countries in 2022","volume":"29","author":"Lazarus","year":"2023","journal-title":"Nature Med."},{"key":"10.1016\/j.vaccine.2025.127775_bb0230","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/jamapediatrics.2022.6243","article-title":"Assessment of efficacy and safety of mRNA COVID-19 vaccines in children aged 5 to 11 years: a systematic review and meta-analysis","volume":"177","author":"Watanabe","year":"2023","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.vaccine.2025.127775_bb0235","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb0240","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-076892","article-title":"Protection of the third-dose and fourth-dose mRNA vaccines against SARS-CoV-2 omicron subvariant: a systematic review and meta-analysis","volume":"13","author":"Rahman","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2025.127775_bb0245","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2025.127775_bb0250","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1586\/erv.09.40","article-title":"Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS","volume":"8","author":"Autran","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.127775_bb0255","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1016\/j.vaccine.2020.03.034","article-title":"Adverse events of interest vary by influenza vaccine type and brand: sentinel network study of eight seasons (2010-2018)","volume":"38","author":"Cross","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127775_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101331","article-title":"Comparative efficacy and safety of vaccines to prevent seasonal influenza: a systematic review and network meta-analysis","volume":"46","author":"Minozzi","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.vaccine.2025.127775_bb0265","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-066182","article-title":"Safety of influenza vaccination during pregnancy: a systematic review","volume":"13","author":"Wolfe","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2025.127775_bb0270","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2330","article-title":"Systematic review of the efficacy, effectiveness and safety of high-dose seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals \u226518 years of age","volume":"33","author":"Comber","year":"2023","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2025.127775_bb0275","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.49881","article-title":"Divergent attitudes toward COVID-19 vaccine vs influenza vaccine","volume":"6","author":"SteelFisher","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2025.127775_bb0280","doi-asserted-by":"crossref","first-page":"7342","DOI":"10.1016\/j.vaccine.2023.10.067","article-title":"Evaluation of intentions to get vaccinated against influenza, COVID 19, pertussis and to get a future vaccine against respiratory syncytial virus in pregnant women","volume":"41","author":"Cubizolles","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127775_bb0285","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41541-019-0132-6","article-title":"The how\u2019s and what\u2019s of vaccine reactogenicity","volume":"4","author":"Herv\u00e9","year":"2019","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2025.127775_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2025.102794","article-title":"Diminishing reactogenicity with preserved immunogenicity in COVID-19 vaccines: a longitudinal observation from primary to updated booster vaccine cohorts","volume":"18","author":"Kang","year":"2025","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.vaccine.2025.127775_bb0295","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/jmv.27424","article-title":"Comparative safety of mRNA COVID-19 vaccines to influenza vaccines: a pharmacovigilance analysis using WHO international database","volume":"94","author":"Kim","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2025.127775_bb0300","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1080\/14760584.2022.2098719","article-title":"Comparing reactogenicity of COVID-19 vaccines: a systematic review and meta-analysis","volume":"21","author":"Sutton","year":"2022","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.127775_bb0305","doi-asserted-by":"crossref","first-page":"e496","DOI":"10.1093\/infdis\/jiad519","article-title":"The Novavax heterologous coronavirus disease 2019 booster demonstrates lower reactogenicity than messenger RNA: a targeted review","volume":"230","author":"Marchese","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2025.106447","article-title":"The immunogenicity, reactogenicity, and safety of a bivalent mRNA or protein COVID-19 vaccine given as a fourth dose","volume":"90","author":"Mazarakis","year":"2025","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2025.127775_bb0315","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s43856-024-00588-7","article-title":"Comparison of physiological and clinical reactions to COVID-19 and influenza vaccination","volume":"4","author":"Yechezkel","year":"2024","journal-title":"Commun Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb0320","doi-asserted-by":"crossref","first-page":"6012","DOI":"10.1038\/s41598-024-56561-w","article-title":"Prediction and detection of side effects severity following COVID-19 and influenza vaccinations: utilizing smartwatches and smartphones","volume":"14","author":"Levi","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2025.127775_bb0325","first-page":"38","article-title":"Effects of COVID-19 and influenza vaccination on rheumatic diseases: results from a survey of patient-reported outcomes after vaccination","author":"Kim","year":"2023","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.vaccine.2025.127775_bb0330","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1186\/s12889-021-11745-1","article-title":"Vaccine hesitancy: evidence from an adverse events following immunization database, and the role of cognitive biases","volume":"21","author":"Azarpanah","year":"2021","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2025.127775_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.therap.2025.02.007","article-title":"Vaccines and the risk of Guillain-Barr\u00e9 syndrome: a French pharmacovigilance analysis","author":"Gligorov","year":"2025","journal-title":"Therapies"},{"key":"10.1016\/j.vaccine.2025.127775_bb0340","doi-asserted-by":"crossref","first-page":"5544","DOI":"10.1016\/j.vaccine.2018.05.119","article-title":"Vaccine-preventable diseases, vaccines and Guillain-Barre\u2019 syndrome","volume":"37","author":"Principi","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127775_bb0345","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.8879","article-title":"Incidence of Guillain-Barr\u00e9 syndrome after COVID-19 vaccination in the vaccine safety datalink","volume":"5","author":"Hanson","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2025.127775_bb0350","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"397","author":"Shahrizaila","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.127775_bb0355","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29693","article-title":"Global estimates on the reports of vaccine-associated myocarditis and pericarditis from 1969 to 2023: findings with critical reanalysis from the WHO pharmacovigilance database","volume":"96","author":"Lee","year":"2024","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2025.127775_bb0360","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/eurheartj\/ehae056","article-title":"Booster vaccination with SARS-CoV-2 mRNA vaccines and myocarditis in adolescents and young adults: a Nordic cohort study","volume":"45","author":"Hviid","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.vaccine.2025.127775_bb0365","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41591-021-01630-0","article-title":"Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection","volume":"28","author":"Patone","year":"2022","journal-title":"Nature Med."},{"key":"10.1016\/j.vaccine.2025.127775_bb0370","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41541-024-00960-7","article-title":"Risk benefit analysis to evaluate risk of thromboembolic events after mRNA COVID-19 vaccination and COVID-19","volume":"9","author":"Tran","year":"2024","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2025.127775_bb0375","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1038\/s41591-021-01556-7","article-title":"Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection","volume":"27","author":"Patone","year":"2021","journal-title":"Nature Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb0380","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1056\/NEJMoa2110475","article-title":"Safety of the BNT162b2 mRNA covid-19 vaccine in a nationwide setting","volume":"385","author":"Barda","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb0385","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/irv.12470","article-title":"The hidden burden of influenza: a review of the extra-pulmonary complications of influenza infection","volume":"11","author":"Sellers","year":"2017","journal-title":"Influenza Other Respi Viruses"},{"key":"10.1016\/j.vaccine.2025.127775_bb0390","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/cid\/ciu005","article-title":"Guillain-Barr\u00e9 syndrome, influenza, and influenza vaccination: the epidemiologic evidence","volume":"58","author":"Vellozzi","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb0395","article-title":"Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study","volume":"374","author":"Hippisley-Cox","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2025.127775_bb0400","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.1016\/j.vaccine.2012.06.093","article-title":"Influenza vaccine, Guillain-Barr\u00e9 syndrome, and chasing zero","volume":"30","author":"Poland","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127775_bb0405","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1161\/CIRCRESAHA.122.321881","article-title":"Vaccination-associated myocarditis and myocardial injury","volume":"132","author":"Altman","year":"2023","journal-title":"Circ Res"},{"key":"10.1016\/j.vaccine.2025.127775_bb0410","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2022-000373","article-title":"Clinical outcomes of myocarditis after SARS-CoV-2 mRNA vaccination in four Nordic countries: population based cohort study","volume":"2","author":"Husby","year":"2023","journal-title":"BMJ Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb0415","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/jama.2024.16380","article-title":"Long-term prognosis of patients with myocarditis attributed to COVID-19 mRNA vaccination, SARS-CoV-2 infection, or conventional etiologies","volume":"332","author":"Semenzato","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2025.127775_bb0420","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41541-023-00681-3","article-title":"Systematic review and meta-analysis of myocarditis and pericarditis in adolescents following COVID-19 BNT162b2 vaccination","volume":"8","author":"Katoto","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2025.127775_bb0425","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1038\/s41467-024-47745-z","article-title":"Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England","volume":"15","author":"Copland","year":"2024","journal-title":"Nature Comm"},{"key":"10.1016\/j.vaccine.2025.127775_bb0430","doi-asserted-by":"crossref","first-page":"977","DOI":"10.15585\/mmwr.mm7027e2","article-title":"Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the advisory committee on immunization practices - United States, June 2021","volume":"70","author":"Gargano","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2025.127775_bb0435","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1016\/j.vaccine.2022.03.030","article-title":"Benefit-risk assessment of COVID-19 vaccine, mRNA (Comirnaty) for age 16-29 years","volume":"40","author":"Funk","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127775_bb0440","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2025.127775_bb0445","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.1038\/s41467-024-50376-z","article-title":"Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phases","volume":"15","author":"Baden","year":"2024","journal-title":"Nature Comm"},{"key":"10.1016\/j.vaccine.2025.127775_bb0450","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1038\/s41467-024-45953-1","article-title":"Persistence in risk and effect of COVID-19 vaccination on long-term health consequences after SARS-CoV-2 infection","volume":"15","author":"Lam","year":"2024","journal-title":"Nature Comm"},{"key":"10.1016\/j.vaccine.2025.127775_bb0455","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1186\/s12916-024-03630-6","article-title":"Association of COVID-19 with acute and post-acute risk of multiple different complications and mortality in patients infected with omicron variant stratified by initial disease severity: a cohort study in Hong Kong","volume":"22","author":"Wan","year":"2024","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb0460","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.127775_bb0465","first-page":"13","article-title":"High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages","author":"Hoepel","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb0470","first-page":"371","article-title":"Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity","author":"Larsen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2025.127775_bb0475","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41586-020-03148-w","article-title":"Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia","volume":"590","author":"Grant","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2025.127775_bb0480","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3949\/ccjm.87a.ccc032","article-title":"Thoracic imaging in COVID-19","volume":"87","author":"Yadav","year":"2020","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb0485","doi-asserted-by":"crossref","first-page":"eabm7853","DOI":"10.1126\/scitranslmed.abm7853","article-title":"Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity","volume":"14","author":"Chakraborty","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb0490","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cellimm.2018.07.009","article-title":"Immunoglobulin G glycosylation in aging and diseases","volume":"333","author":"Gudelj","year":"2018","journal-title":"Cell Immunol"},{"key":"10.1016\/j.vaccine.2025.127775_bb0495","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.it.2022.08.001","article-title":"Afucosylated IgG responses in humans - structural clues to the regulation of humoral immunity","volume":"43","author":"Oosterhoff","year":"2022","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2025.127775_bb0500","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.cell.2020.08.001","article-title":"Severe COVID-19 is marked by a dysregulated myeloid cell compartment","volume":"182","author":"Schulte-Schrepping","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2025.127775_bb0505","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adq1086","article-title":"Prior vaccination prevents overactivation of innate immune responses during COVID-19 breakthrough infection","volume":"17","author":"Chan","year":"2025","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb0510","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/s41591-021-01386-7","article-title":"CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer","volume":"27","author":"Bange","year":"2021","journal-title":"Nature Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105809","article-title":"Vaccine-induced T cell responses correlate with reduced risk of severe COVID-19 in a placebo-controlled efficacy trial","volume":"117","author":"Hertoghs","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.vaccine.2025.127775_bb0520","first-page":"6","article-title":"CD8(+) T cells specific for conserved coronavirus epitopes correlate with milder disease in COVID-19 patients","author":"Mallajosyula","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.vaccine.2025.127775_bb0525","first-page":"12","article-title":"Recovery from acute SARS-CoV-2 infection and development of anamnestic immune responses in T cell-depleted rhesus macaques","author":"Hasenkrug","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2025.127775_bb0530","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009668","article-title":"Subacute SARS-CoV-2 replication can be controlled in the absence of CD8+ T cells in cynomolgus macaques","volume":"17","author":"Nomura","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2025.127775_bb0535","first-page":"71","article-title":"Comparison of severity of immunized versus non-immunized COVID-19 patients admitted to ICU: a prospective observational study","author":"Mhawish","year":"2021","journal-title":"Ann Med Surg (Lond)"},{"key":"10.1016\/j.vaccine.2025.127775_bb0540","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ijid.2021.10.032","article-title":"Measuring the impact of a single dose of ChAdOx1 nCoV-19 (recombinant) coronavirus vaccine on hospital stay, ICU requirement, and mortality outcome in a tertiary care centre","volume":"113","author":"Desai","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb0545","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/jama.2022.12992","article-title":"Association between vaccination and acute myocardial infarction and ischemic stroke after COVID-19 infection","volume":"328","author":"Kim","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2025.127775_bb0550","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1056\/NEJMoa2403211","article-title":"Postacute sequelae of SARS-CoV-2 infection in the pre-delta, delta, and omicron eras","volume":"391","author":"Xie","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb0555","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.cmi.2024.01.028","article-title":"Vaccination and the risk of post-acute sequelae after COVID-19 in the omicron-predominant period","volume":"30","author":"Huh","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2025.127775_bb0560","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41467-017-00928-3","article-title":"Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza a virus in mice","volume":"8","author":"He","year":"2017","journal-title":"Nature Comm"},{"key":"10.1016\/j.vaccine.2025.127775_bb0565","doi-asserted-by":"crossref","unstructured":"Chakraborty S, Cheng BY, Edwards DL, Gonzalez JC, Chiu DK, Zheng H, et al. Sialylated IgG induces the transcription factor REST in alveolar macrophages to protect against lung inflammation and severe influenza disease. Immunity 2025;58:182\u2013196.e10. doi: https:\/\/doi.org\/10.1016\/j.immuni.2024.10.002.","DOI":"10.1016\/j.immuni.2024.10.002"},{"key":"10.1016\/j.vaccine.2025.127775_bb0570","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.014563","article-title":"Changes in antigen-specific IgG1 fc N-glycosylation upon influenza and tetanus vaccination","volume":"11","author":"Selman","year":"2012","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.vaccine.2025.127775_bb0575","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cell.2015.06.026","article-title":"Anti-HA glycoforms drive B cell affinity selection and determine influenza vaccine efficacy","volume":"162","author":"Wang Taia","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2025.127775_bb0580","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/iid3.22","article-title":"A pilot study showing differences in glycosylation patterns of IgG subclasses induced by pneumococcal, meningococcal, and two types of influenza vaccines","volume":"2","author":"Vestrheim","year":"2014","journal-title":"Immunity Inflamm Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb0585","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/imcb.12312","article-title":"The protective potential of fc-mediated antibody functions against influenza virus and other viral pathogens","volume":"98","author":"Vanderven","year":"2020","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2025.127775_bb0590","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1016\/j.vaccine.2021.05.011","article-title":"Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research","volume":"39","author":"Ferdinands","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127775_bb0595","doi-asserted-by":"crossref","DOI":"10.1007\/s41999-024-01002-0","article-title":"Differences in characteristics and outcomes of older patients hospitalized for COVID-19 after introduction of vaccination","author":"Smits","year":"2024","journal-title":"Eur Geriatr Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb0600","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1586\/14760584.2016.1134328","article-title":"Effect of influenza vaccination on the prognosis of hospitalized influenza patients","volume":"15","author":"Casado","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.127775_bb0605","doi-asserted-by":"crossref","first-page":"5916","DOI":"10.1016\/j.vaccine.2018.07.028","article-title":"Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012\u20132015","volume":"36","author":"Thompson","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127775_bb0610","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066312","article-title":"Influenza illness and hospitalizations averted by influenza vaccination in the United States, 2005-2011","volume":"8","author":"Kostova","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2025.127775_bb0615","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2025.127775_bb0620","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/14760584.2024.2331065","article-title":"The durability of vaccine-induced protection: an overview","volume":"23","author":"Vashishtha","year":"2024","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.127775_bb0625","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2025.127775_bb0630","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.immuni.2022.10.017","article-title":"Sterilizing immunity: understanding COVID-19","volume":"55","author":"Wahl","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2025.127775_bb0635","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/s41591-020-1083-1","article-title":"Seasonal coronavirus protective immunity is short-lasting","volume":"26","author":"Edridge","year":"2020","journal-title":"Nature Med."},{"key":"10.1016\/j.vaccine.2025.127775_bb0640","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/infdis\/jiaa392","article-title":"Direct observation of repeated infections with endemic coronaviruses","volume":"223","author":"Galanti","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb0645","doi-asserted-by":"crossref","first-page":"e863","DOI":"10.1016\/S2214-109X(21)00141-8","article-title":"Asymptomatic transmission and high community burden of seasonal influenza in an urban and a rural community in South Africa, 2017-18 (PHIRST): a population cohort study","volume":"9","author":"Cohen","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2025.127775_bb0650","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/aje\/kws121","article-title":"The epidemiology of interpandemic and pandemic influenza in Vietnam, 2007-2010: the Ha Nam household cohort study I","volume":"175","author":"Horby","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2025.127775_bb0655","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S0140-6736(22)02634-4","article-title":"COVID-19 infection, reinfection, and the transition to endemicity","volume":"401","author":"Cohen","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.127775_bb0660","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/infdis\/163.4.693","article-title":"Immunity to and frequency of reinfection with respiratory syncytial virus","volume":"163","author":"Hall","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb0665","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/jmv.21920","article-title":"Longitudinal course of human metapneumovirus antibody titers and reinfection in healthy adults","volume":"82","author":"Okamoto","year":"2010","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2025.127775_bb0670","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/cid\/ciw816","article-title":"Intraseason waning of influenza vaccine protection: evidence from the US influenza vaccine effectiveness network, 2011\u20132012 through 2014\u20132015","volume":"64","author":"Ferdinands","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb0675","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.vaccine.2014.06.052","article-title":"Waning vaccine protection against influenza a (H3N2) illness in children and older adults during a single season","volume":"33","author":"Belongia","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127775_bb0680","article-title":"I-MOVE multicentre case\u2013control study 2010\/11 to 2014\/15: is there within-season waning of influenza type\/subtype vaccine effectiveness with increasing time since vaccination?","volume":"21","author":"Kissling","year":"2016","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2025.127775_bb0685","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1080\/14760584.2024.2331073","article-title":"Waning intra-season vaccine effectiveness against influenza A(H3N2) underlines the need for more durable protection","volume":"23","author":"Domnich","year":"2024","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.127775_bb0690","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2024.29.8.2300239","article-title":"Measuring waning protection from seasonal influenza vaccination during nine influenza seasons, Ontario, Canada, 2010\/11 to 2018\/19","volume":"29","author":"Chung","year":"2024","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2025.127775_bb0695","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1093\/cid\/ciy770","article-title":"Intraseason waning of influenza vaccine effectiveness","volume":"68","author":"Ray","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb0700","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/icb.2011.38","article-title":"Seasoned adaptive antibody immunity for highly pathogenic pandemic influenza in humans","volume":"90","author":"Lynch","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2025.127775_bb0705","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12916-022-02397-y","article-title":"Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis","volume":"20","author":"Zeng","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb0710","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2167410","article-title":"Effectiveness of the pre-omicron COVID-19 vaccines against omicron in reducing infection, hospitalization, severity, and mortality compared to Delta and other variants: a systematic review","volume":"19","author":"Paul","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.127775_bb0715","first-page":"34","article-title":"Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults: a systematic review and meta-analysis of European studies published up to 22 January 2024","author":"Zhou","year":"2025","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.vaccine.2025.127775_bb0720","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(22)00152-0","article-title":"Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression","volume":"399","author":"Feikin","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.127775_bb0725","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1016\/j.vaccine.2023.08.072","article-title":"Comparative effectiveness and duration of protection of ChAdOx1, CoronaVac, BNT162b2, mRNA-1273, and Ad26.COV2.S COVID-19 vaccines for symptomatic and hospitalized mu, delta, and omicron: a test-negative case-control study","volume":"41","author":"Paternina-Caicedo","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127775_bb0730","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1195908","article-title":"Effectiveness of SARS-CoV-2 vaccines against omicron infection and severe events: a systematic review and meta-analysis of test-negative design studies","volume":"11","author":"Song","year":"2023","journal-title":"Front Public Health"},{"key":"10.1016\/j.vaccine.2025.127775_bb0735","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41591-024-03278-y","article-title":"SARS-CoV-2-specific plasma cells are not durably established in the bone marrow long-lived compartment after mRNA vaccination","volume":"31","author":"Nguyen","year":"2025","journal-title":"Nature Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb0740","doi-asserted-by":"crossref","first-page":"eadd5960","DOI":"10.1126\/scitranslmed.add5960","article-title":"Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primates","volume":"16","author":"Prabhakaran","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb0745","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29170","article-title":"Early humoral and cellular responses after bivalent SARS-CoV-2 mRNA-1273.214 vaccination in long-term care and retirement home residents in Ontario, Canada: an observational cohort study","volume":"95","author":"Breznik","year":"2023","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2025.127775_bb0750","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41579-023-00878-2","article-title":"The evolution of SARS-CoV-2","volume":"21","author":"Markov","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2025.127775_bb0755","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev-immunol-083122-043054","article-title":"SARS-CoV-2: the interplay between evolution and host immunity","volume":"43","author":"Case","year":"2025","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2025.127775_bb0760","doi-asserted-by":"crossref","first-page":"77","DOI":"10.15585\/mmwr.mm7304a2","volume":"73","author":"Link-Gelles","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2025.127775_bb0765","doi-asserted-by":"crossref","first-page":"175","DOI":"10.15585\/mmwr.mm7308a4","article-title":"Interim influenza vaccine effectiveness against laboratory-confirmed influenza - California, October 2023-January 2024","volume":"73","author":"Zhu","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2025.127775_bb0770","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jamda.2023.02.105","article-title":"Protection from omicron infection in residents of nursing and retirement homes in Ontario, Canada","volume":"24","author":"Breznik","year":"2023","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.vaccine.2025.127775_bb0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105180","article-title":"Durability of immunity and clinical protection in nursing home residents following bivalent SARS-CoV-2 vaccination","volume":"105","author":"Gravenstein","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.vaccine.2025.127775_bb0780","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1038\/s41467-023-38275-1","article-title":"Protection against SARS-CoV-2 omicron BA.4\/5 variant following booster vaccination or breakthrough infection in the UK","volume":"14","author":"Wei","year":"2023","journal-title":"Nature Comm"},{"key":"10.1016\/j.vaccine.2025.127775_bb0785","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12916-024-03304-3","article-title":"Correlates of protection and determinants of SARS-CoV-2 breakthrough infections 1 year after third dose vaccination","volume":"22","author":"Mart\u00edn P\u00e9rez","year":"2024","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb0790","doi-asserted-by":"crossref","first-page":"7660","DOI":"10.1016\/j.vaccine.2022.10.049","article-title":"Association between COVID-19 vaccination status, time elapsed since the last vaccine dose, morbidity, and absenteeism among healthcare personnel: a prospective, multicenter study","volume":"40","author":"Maltezou","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127775_bb0795","doi-asserted-by":"crossref","first-page":"182","DOI":"10.5271\/sjweh.4077","article-title":"Return-to-work rates and predictors of absence duration after COVID-19 over the course of the pandemic","volume":"49","author":"Aben","year":"2023","journal-title":"Scand J Work Environ Health"},{"key":"10.1016\/j.vaccine.2025.127775_bb0800","doi-asserted-by":"crossref","first-page":"9127","DOI":"10.1016\/j.vaccine.2011.09.112","article-title":"Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine","volume":"29","author":"Miller","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127775_bb0805","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.294.16.2043","article-title":"Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine","volume":"294","author":"Lexau","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2025.127775_bb0810","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1056\/NEJMoa1209165","article-title":"U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination","volume":"369","author":"Griffin","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb0815","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.3201\/eid3009.240259","article-title":"Effects of rotavirus vaccination coverage among infants on hospital admission for gastroenteritis across all age groups, Japan, 2011-2019","volume":"30","author":"Kishimoto","year":"2024","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb0820","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf1374","article-title":"Vaccine optimization for COVID-19: who to vaccinate first?","volume":"7","author":"Matrajt","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.vaccine.2025.127775_bb0825","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.2010.250","article-title":"Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial","volume":"303","author":"Loeb","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2025.127775_bb0830","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1016\/j.vaccine.2012.05.008","article-title":"Effects of immunizing school children with 2009 influenza A (H1N1) monovalent vaccine on absenteeism among students and teachers in Maine","volume":"30","author":"Graitcer","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127775_bb0835","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.vaccine.2011.10.097","article-title":"Direct and indirect impact of influenza vaccination of young children on school absenteeism","volume":"30","author":"King","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127775_bb0840","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/j.vaccine.2021.02.020","article-title":"Workplace influenza vaccination to reduce employee absenteeism: an economic analysis from the employers\u2019 perspective","volume":"39","author":"Verelst","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127775_bb0845","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(99)05190-9","article-title":"Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial","volume":"355","author":"Carman","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.127775_bb0850","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2013.18.26.20512","article-title":"Hospital-based cluster randomised controlled trial to assess effects of a multi-faceted programme on influenza vaccine coverage among hospital healthcare workers and nosocomial influenza in the Netherlands, 2009 to 2011","volume":"18","author":"Riphagen-Dalhuisen","year":"2013","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2025.127775_bb0855","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1038\/s41467-022-33328-3","article-title":"Household transmission of the SARS-CoV-2 omicron variant in Denmark","volume":"13","author":"Lyngse","year":"2022","journal-title":"Nature Comm"},{"key":"10.1016\/j.vaccine.2025.127775_bb0860","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/s41467-024-55029-9","article-title":"Strength and durability of indirect protection against SARS-CoV-2 infection through vaccine and infection-acquired immunity","volume":"16","author":"Tan","year":"2025","journal-title":"Nature Comm"},{"key":"10.1016\/j.vaccine.2025.127775_bb0865","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41591-022-02138-x","article-title":"Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the omicron wave","volume":"29","author":"Tan","year":"2023","journal-title":"Nature Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb0870","article-title":"Reduced risk of SARS-CoV-2 infection among household contacts with recent vaccination and past COVID-19 infection: results from two multi-site case-ascertained household transmission studies","author":"Rolfes","year":"2024","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2025.127775_bb0875","first-page":"38","article-title":"Vaccine effect on household transmission of omicron and delta SARS-CoV-2 variants","author":"Kim","year":"2023","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.vaccine.2025.127775_bb0880","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S1473-3099(23)00373-0","article-title":"Effectiveness of bivalent mRNA vaccines against medically attended symptomatic SARS-CoV-2 infection and COVID-19-related hospital admission among SARS-CoV-2-naive and previously infected individuals: a retrospective cohort study","volume":"23","author":"Tan","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb0885","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.1038\/s41467-022-33233-9","article-title":"Increased household transmission and immune escape of the SARS-CoV-2 omicron compared to Delta variants","volume":"13","author":"Jalali","year":"2022","journal-title":"Nature Comm"},{"key":"10.1016\/j.vaccine.2025.127775_bb0890","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1038\/s41467-022-33498-0","article-title":"Household transmission of SARS-CoV-2 omicron variant of concern subvariants BA.1 and BA.2 in Denmark","volume":"13","author":"Lyngse","year":"2022","journal-title":"Nature Comm"},{"key":"10.1016\/j.vaccine.2025.127775_bb0895","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2025.100638","article-title":"Household transmission of the SARS-CoV-2 omicron variant in New Zealand, 2022","volume":"24","author":"Aminisani","year":"2025","journal-title":"Vaccine X"},{"key":"10.1016\/j.vaccine.2025.127775_bb0900","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s43856-024-00521-y","article-title":"Transmission risks of omicron BA.5 following inactivated COVID-19 vaccines among children and adolescents in China","volume":"4","author":"Guo","year":"2024","journal-title":"Commun Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb0905","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0313680","article-title":"Household transmission of SARS-CoV-2 in five US jurisdictions: comparison of delta and omicron variants","volume":"20","author":"Baker","year":"2025","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2025.127775_bb0910","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e28042","article-title":"Vaccination strategies impact the probability of outbreak extinction: a case study of COVID-19 transmission","volume":"10","author":"Jitsuk","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.vaccine.2025.127775_bb0915","first-page":"3","article-title":"Influenza vaccine allocation in tropical settings under constrained resources","author":"Servadio","year":"2024","journal-title":"PNAS Nexus"},{"key":"10.1016\/j.vaccine.2025.127775_bb0920","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2023.28.18.2200624","article-title":"The role of children in transmission of SARS-CoV-2 variants of concern within households: an updated systematic review and meta-analysis, as at 30 June 2022","volume":"28","author":"Zhu","year":"2023","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2025.127775_bb0925","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ijid.2023.06.017","article-title":"Effect of COVID-19 vaccination on household transmission of SARS-CoV-2 in the omicron era: the vaccine effectiveness, networking, and universal safety (VENUS) study","volume":"134","author":"Maeda","year":"2023","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb0930","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/infdis\/jiae546","article-title":"Lower levels of household transmission of SARS-CoV-2 omicron variant of concern vs wild type: an interplay between transmissibility and immune status","volume":"231","author":"Winkel","year":"2025","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb0935","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41586-022-04479-6","article-title":"SARS-CoV-2 omicron variant replication in human bronchus and lung ex vivo","volume":"603","author":"Hui","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2025.127775_bb0940","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2023.01.030","article-title":"Epidemiological, clinical, and household transmission characteristics of children and adolescents infected with SARS-CoV-2 omicron variant in Shanghai, China: a retrospective, multicenter observational study","volume":"129","author":"Liu","year":"2023","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb0945","first-page":"35","article-title":"Understanding SARS-CoV-2 Delta and omicron variant transmission and vaccine impact in schools and child-care settings in Australia: a population-based study","author":"Koirala","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.vaccine.2025.127775_bb0950","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaf200","article-title":"The impact of influenza on US working-age adults: exploring the benefits of the recombinant influenza vaccine","author":"Torcel-Pagnon","year":"2025","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb0955","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.socscimed.2017.12.011","article-title":"Do we consider paid sick leave when deciding to get vaccinated?","volume":"198","author":"Kim","year":"2018","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb0960","doi-asserted-by":"crossref","first-page":"7316","DOI":"10.1016\/j.vaccine.2018.10.039","article-title":"Paid sick leave benefits, influenza vaccination, and taking sick days due to influenza-like illness among U.S. workers","volume":"36","author":"Zhai","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127775_bb0965","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272332","article-title":"Influenza vaccination of school teachers: a scoping review and an impact estimation","volume":"17","author":"Huiberts","year":"2022","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2025.127775_bb0970","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.vaccine.2015.01.048","article-title":"Healthcare worker influenza immunization vaccinate or mask policy: strategies for cost effective implementation and subsequent reductions in staff absenteeism due to illness","volume":"33","author":"Van Buynder","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127775_bb0975","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/14760584.2019.1586541","article-title":"Seasonal influenza vaccination and absenteeism in health-care workers in two subsequent influenza seasons (2016\/17 and 2017\/18) in an Italian pediatric hospital","volume":"18","author":"Zaffina","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.127775_bb0980","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.ajem.2007.02.002","article-title":"Does vaccinating ED health care workers against influenza reduce sickness absenteeism?","volume":"25","author":"Chan","year":"2007","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb0985","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7861\/clinmedicine.17-6-484","article-title":"Healthcare worker influenza vaccination and sickness absence - an ecological study","volume":"17","author":"Pereira","year":"2017","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.vaccine.2025.127775_bb0990","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/00006454-199909000-00007","article-title":"Randomized, placebo-controlled double blind study on the efficacy of influenza immunization on absenteeism of health care workers","volume":"18","author":"Sax\u00e9n","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2025.127775_bb0995","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1186\/s12889-024-19374-0","article-title":"Estimating vaccine effectiveness against COVID-19 using cause-specific sick leave as an indicator: a nationwide population-based cohort study, Norway, July 2021 \u2013 December 2022","volume":"24","author":"Meijerink","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2025.127775_bb1000","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1177\/14034948221123163","article-title":"Impact of omicron on sick leave across industries: a population-wide study","volume":"51","author":"Gr\u00f8sland","year":"2023","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.vaccine.2025.127775_bb1005","article-title":"Introduction to the GRADE tool for rating certainty in evidence and recommendations","volume":"25","author":"Prasad","year":"2024","journal-title":"Clin Epidemiol Glob Health"},{"key":"10.1016\/j.vaccine.2025.127775_bb1010","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.vaccine.2024.01.040","article-title":"The association between influenza vaccination, cardiovascular mortality and hospitalization: a living systematic review and prospective meta-analysis","volume":"42","author":"Liu","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127775_bb1015","series-title":"Encyclopedia of gerontology and population aging","first-page":"1146","article-title":"Consequences of pneumonia in older adults","author":"Orihuela","year":"2021"},{"key":"10.1016\/j.vaccine.2025.127775_bb1020","doi-asserted-by":"crossref","DOI":"10.2196\/53580","article-title":"Impact of long SARS-CoV-2 omicron infection on the health care burden: comparative case-control study between omicron and pre-omicron waves","volume":"10","author":"Valdivieso-Martinez","year":"2024","journal-title":"JMIR Public Health Surveill"},{"key":"10.1016\/j.vaccine.2025.127775_bb1025","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1080\/13696998.2023.2281882","article-title":"The impact of vaccination and outpatient treatment on the economic burden of Covid-19 in the United States omicron era: a systematic literature review","volume":"26","author":"Pierre","year":"2023","journal-title":"J Med Econ"},{"key":"10.1016\/j.vaccine.2025.127775_bb1030","article-title":"The effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions: a systematic literature review and meta-analysis of the latest research","volume":"3","author":"Marra","year":"2023","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"10.1016\/j.vaccine.2025.127775_bb1035","first-page":"53","article-title":"Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: a systematic review","author":"Notarte","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.vaccine.2025.127775_bb1040","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1001\/jama.2022.5471","article-title":"Antibiotic prescriptions associated with COVID-19 outpatient visits among Medicare beneficiaries, April 2020 to April 2021","volume":"327","author":"Tsay","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2025.127775_bb1045","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/cid\/ciad190","article-title":"Coronavirus disease 2019 vaccination is associated with reduced outpatient antibiotic prescribing in older adults with confirmed severe acute respiratory syndrome coronavirus 2: a population-wide cohort study","volume":"77","author":"MacFadden","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb1050","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.cmi.2019.06.030","article-title":"Impact of vaccination on antibiotic usage: a systematic review and meta-analysis","volume":"25","author":"Buckley","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2025.127775_bb1055","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13756-023-01272-6","article-title":"The impact of influenza and pneumococcal vaccination on antibiotic use: an updated systematic review and meta-analysis","volume":"12","author":"van Heuvel","year":"2023","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.vaccine.2025.127775_bb1060","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/07853890.2020.1782460","article-title":"Effect of vaccination on the use of antimicrobial agents: a systematic literature review","volume":"52","author":"Doherty","year":"2020","journal-title":"Ann Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb1065","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.chom.2024.05.015","article-title":"Antibiotic resistance: a key microbial survival mechanism that threatens public health","volume":"32","author":"Abbas","year":"2024","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2025.127775_bb1070","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2025.127775_bb1075","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2025.127775_bb1080","doi-asserted-by":"crossref","first-page":"70","DOI":"10.18295\/squmj.9.2023.053","article-title":"Frequency of asthma exacerbations and upper respiratory tract infections among adults with asthma according to vaccination status: does the annual influenza vaccine have a protective effect?","volume":"24","author":"Kharusi","year":"2024","journal-title":"Sultan Qaboos Univ Med J"},{"key":"10.1016\/j.vaccine.2025.127775_bb1085","doi-asserted-by":"crossref","first-page":"E1120","DOI":"10.1503\/cmaj.201757","article-title":"Effect of influenza vaccination in patients with asthma","volume":"193","author":"Mart\u00ednez-Baz","year":"2021","journal-title":"CMAJ"},{"key":"10.1016\/j.vaccine.2025.127775_bb1090","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000364.pub4","article-title":"Vaccines for preventing influenza in people with asthma","author":"Cates","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2025.127775_bb1095","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2024.05.017","article-title":"A Nationwide cohort study of Delta and omicron SARS-CoV-2 outcomes in vaccinated individuals with chronic lung disease","author":"Wee","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.vaccine.2025.127775_bb1100","first-page":"752","article-title":"Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: a longitudinal population-based study (COVIDENCE UK)","volume":"78","author":"Tydeman","year":"2023","journal-title":"Thorax"},{"key":"10.1016\/j.vaccine.2025.127775_bb1105","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1002\/ppul.26642","article-title":"Odds of COVID-19-associated asthma exacerbations in children higher during omicron wave","volume":"58","author":"Gaietto","year":"2023","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.vaccine.2025.127775_bb1110","article-title":"COVID-19 severity and risk of SARS-CoV-2-associated asthma exacerbation by time since booster vaccination: a longitudinal analysis of data from the COVIDENCE UK study","volume":"12","author":"Vivaldi","year":"2024","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.vaccine.2025.127775_bb1115","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.19979","article-title":"COVID-19 vaccination and parent-reported symptomatic child asthma prevalence","volume":"7","author":"Davis","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127775_bb1120","article-title":"Influenza vaccine for chronic obstructive pulmonary disease (COPD)","author":"Kopsaftis","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2025.127775_bb1125","author":"Public Health Agency of Canada"},{"key":"10.1016\/j.vaccine.2025.127775_bb1130","doi-asserted-by":"crossref","first-page":"13881","DOI":"10.1038\/s41598-024-64670-9","article-title":"Outcomes among patients with chronic obstructive pulmonary disease after recovery from COVID-19 infection of different severity","volume":"14","author":"Kwok","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2025.127775_bb1135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1473-3099(09)70331-7","article-title":"Role of acute infection in triggering acute coronary syndromes","volume":"10","author":"Corrales-Medina","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb1140","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/infdis\/jir171","article-title":"Circulating influenza virus, climatic factors, and acute myocardial infarction: a time series study in England and Wales and Hong Kong","volume":"203","author":"Warren-Gash","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb1145","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1136\/heartjnl-2015-307691","article-title":"Acute myocardial infarction and influenza: a meta-analysis of case\u2013control studies","volume":"101","author":"Barnes","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.vaccine.2025.127775_bb1150","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s11886-022-01748-8","article-title":"Influenza vaccination for cardiovascular prevention: further insights from the IAMI trial and an updated meta-analysis","volume":"24","author":"Maniar","year":"2022","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.vaccine.2025.127775_bb1155","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1056\/NEJMoa025028","article-title":"Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly","volume":"348","author":"Nichol","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb1160","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000478017","article-title":"Effect of influenza vaccination on risk of stroke: a systematic review and meta-analysis","volume":"48","author":"Lee","year":"2017","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.vaccine.2025.127775_bb1165","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/01.STR.0000170674.45136.80","article-title":"Influenza vaccination is associated with a reduced risk of stroke","volume":"36","author":"Grau","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.vaccine.2025.127775_bb1170","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1016\/j.jinf.2022.08.008","article-title":"Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 omicron BA.2 infection, hospitalisation, severe complications, cardiovascular disease and mortality in patients with diabetes mellitus: a case control study","volume":"85","author":"Wan","year":"2022","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2025.127775_bb1175","article-title":"Risk factors for COVID-19 hospitalization or death during the first Omicron surge in adults: a large population-based case-control study","author":"Lo","year":"2022","journal-title":"medRxiv"},{"key":"10.1016\/j.vaccine.2025.127775_bb1180","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126356","article-title":"Risk of death and cardiovascular events following COVID-19 vaccination or positive SARS-CoV-2 test amongst adult Singaporeans during omicron transmission","volume":"42","author":"Wee","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127775_bb1185","first-page":"1104","article-title":"Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries","volume":"43","author":"LEOSS Study Group","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.vaccine.2025.127775_bb1190","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/cid\/ciae598","article-title":"Bivalent boosters and risk of postacute sequelae following vaccine-breakthrough SARS-CoV-2 omicron infection: a cohort study","volume":"80","author":"Wee","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb1195","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.2105\/AJPH.2011.300606","article-title":"H1N1 influenza vaccination during pregnancy and fetal and neonatal outcomes","volume":"102","author":"Fell","year":"2012","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2025.127775_bb1200","first-page":"1085","article-title":"Immunization in pregnancy","volume":"31","author":"Gruslin","year":"2009","journal-title":"JOGC"},{"key":"10.1016\/j.vaccine.2025.127775_bb1205","doi-asserted-by":"crossref","unstructured":"Wilde H, Tomlinson C, Mateen BA, Selby D, Kanthimathinathan HK, Denaxas S, et al. Trends in pediatric hospital admissions caused or contributed by SARS-CoV-2 infection in England. J Pediatr doi: https:\/\/doi.org\/10.1016\/j.jpeds.2024.114370.","DOI":"10.1016\/j.jpeds.2024.114370"},{"key":"10.1016\/j.vaccine.2025.127775_bb1210","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(22)02467-9","article-title":"Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study","volume":"401","author":"Villar","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.127775_bb1215","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/uog.24916","article-title":"Maternal and perinatal outcomes of SARS-CoV-2 infection in unvaccinated pregnancies during Delta and omicron waves","volume":"60","author":"Birol Ilter","year":"2022","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2025.127775_bb1220","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2022-000190","article-title":"Severity of maternal SARS-CoV-2 infection and perinatal outcomes of women admitted to hospital during the omicron variant dominant period using UK obstetric surveillance system data: prospective, national cohort study","volume":"1","author":"Engjom","year":"2022","journal-title":"BMJ Med."},{"key":"10.1016\/j.vaccine.2025.127775_bb1225","first-page":"26","article-title":"Maternal and perinatal outcomes following pre-Delta, Delta, and omicron SARS-CoV-2 variants infection among unvaccinated pregnant women in France and Switzerland: a prospective cohort study using the COVI-PREG registry","author":"Favre","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.vaccine.2025.127775_bb1230","first-page":"45","article-title":"COVID-19 vaccination and birth outcomes of 186,990 women vaccinated before pregnancy: an England-wide cohort study","author":"Suseeladevi","year":"2024","journal-title":"Lancet Reg Health Eur."},{"key":"10.1016\/j.vaccine.2025.127775_bb1235","doi-asserted-by":"crossref","DOI":"10.1097\/INF.0000000000004813","article-title":"Prenatal maternal COVID-19 and offspring risk for morbidities up to the age of one year","author":"Lavi","year":"2025","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2025.127775_bb1240","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae481","article-title":"Effectiveness of the original monovalent and bivalent COVID-19 vaccines against COVID-19\u2013associated emergency department and urgent care encounters in pregnant persons who were not immunocompromised: VISION network, June 2022\u2013August 2023","volume":"11","author":"Avrich Ciesla","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb1245","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1017\/ice.2024.50","article-title":"Predictors of SARS-CoV-2 transmission in congregate living settings: a multicenter prospective study","volume":"45","author":"Leis","year":"2024","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.vaccine.2025.127775_bb1250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0003490","article-title":"COVID-19 vaccine effectiveness among South Asians in Canada","volume":"4","author":"Chanchlani","year":"2024","journal-title":"PLOS Glob Public Health"},{"key":"10.1016\/j.vaccine.2025.127775_bb1255","doi-asserted-by":"crossref","DOI":"10.2196\/45513","article-title":"The clinical severity of COVID-19 variants of concern: retrospective population-based analysis","volume":"10","author":"Harrigan","year":"2024","journal-title":"JMIR Public Health Surveillance"},{"key":"10.1016\/j.vaccine.2025.127775_bb1260","first-page":"e1","article-title":"Interventions to mitigate the impact of COVID-19 among people experiencing sheltered homelessness: Chicago, Illinois, March 1, 2020-May 11","volume":"2024","author":"Tietje","year":"2023","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2025.127775_bb1265","article-title":"Racial and ethnic disparities and the national burden of COVID-19 on inpatient hospitalizations: a retrospective study in the United States in the year 2020","author":"Nguyen","year":"2024","journal-title":"J Racial Ethn Health Disparities"},{"key":"10.1016\/j.vaccine.2025.127775_bb1270","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.48003","article-title":"Social vulnerability, intervention utilization, and outcomes in US adults hospitalized with influenza","volume":"7","author":"Adams","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2025.127775_bb1275","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.21880","article-title":"Rates of influenza-associated hospitalization, intensive care unit admission, and in-hospital death by race and ethnicity in the United States from 2009 to 2019","volume":"4","author":"O\u2019Halloran","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2025.127775_bb1280","author":"National Center for Health Statistics"},{"key":"10.1016\/j.vaccine.2025.127775_bb1285","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12890-025-03543-x","article-title":"Asthma control after recovery from mild to moderate COVID-19: from Omicron BA.2 to XBB- from a cohort in a university hospital in Hong Kong","volume":"25","author":"Kwok","year":"2025","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb1290","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12916-024-03589-4","article-title":"New-onset obstructive airway disease following COVID-19: a multicenter retrospective cohort study","volume":"22","author":"Chuang","year":"2024","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb1295","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2147\/COPD.S234942","article-title":"Economic burden of chronic obstructive pulmonary disease (COPD): a systematic literature review","volume":"15","author":"Iheanacho","year":"2020","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb1300","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/thoraxjnl-2011-201518","article-title":"Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality","volume":"67","author":"Suissa","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.vaccine.2025.127775_bb1305","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/thx.2005.040527","article-title":"Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease","volume":"60","author":"Soler-Catalu\u00f1a","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.vaccine.2025.127775_bb1310","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jinf.2023.01.012","article-title":"Estimating the contribution of respiratory pathogens to acute exacerbations of COPD using routine data","volume":"86","author":"Sivakumaran","year":"2023","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2025.127775_bb1315","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00258-2024","article-title":"Post-pandemic seasonal dynamics of hospitalised COPD exacerbations and aetiologies in COPD population","author":"Aung","year":"2024","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.vaccine.2025.127775_bb1320","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1513\/AnnalsATS.202311-974OC","article-title":"COVID-19 severity and mortality in veterans with chronic lung disease","volume":"21","author":"Crothers","year":"2024","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.vaccine.2025.127775_bb1325","first-page":"10","article-title":"Estimated causal effects of common respiratory infections on cardiovascular risk: a meta-analysis","author":"la Roi-Teeuw","year":"2023","journal-title":"Open Heart"},{"key":"10.1016\/j.vaccine.2025.127775_bb1330","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1164\/rccm.201701-0104OC","article-title":"Severe pneumococcal pneumonia causes acute cardiac toxicity and subsequent cardiac remodeling","volume":"196","author":"Reyes","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb1335","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ijcard.2008.04.044","article-title":"Cardiovascular manifestations associated with influenza virus infection","volume":"130","author":"Mamas","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.vaccine.2025.127775_bb1340","doi-asserted-by":"crossref","first-page":"20235","DOI":"10.1038\/s41598-023-47690-9","article-title":"Influenza vaccination and major cardiovascular risk: a systematic review and meta-analysis of clinical trials studies","volume":"13","author":"Omidi","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2025.127775_bb1345","doi-asserted-by":"crossref","first-page":"e914","DOI":"10.1016\/S2468-2667(22)00222-5","article-title":"Association between influenza vaccination and risk of stroke in Alberta, Canada: a population-based study","volume":"7","author":"Holodinsky","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.vaccine.2025.127775_bb1350","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1038\/s41467-024-46497-0","article-title":"Impact of vaccination on the association of COVID-19 with cardiovascular diseases: an OpenSAFELY cohort study","volume":"15","author":"Cezard","year":"2024","journal-title":"Nature Comm"},{"key":"10.1016\/j.vaccine.2025.127775_bb1355","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/heartjnl-2023-323483","article-title":"The role of COVID-19 vaccines in preventing post-COVID-19 thromboembolic and cardiovascular complications","volume":"110","author":"Mercad\u00e9-Besora","year":"2024","journal-title":"Heart"},{"key":"10.1016\/j.vaccine.2025.127775_bb1360","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1161\/CIRCRESAHA.123.321876","article-title":"Cell-specific mechanisms in the heart of COVID-19 patients","volume":"132","author":"Tsai","year":"2023","journal-title":"Circ Res"},{"key":"10.1016\/j.vaccine.2025.127775_bb1365","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001290","article-title":"Cardiac arrhythmias and autonomic dysfunction associated with COVID-19: a scientific statement from the American Heart Association","author":"Gopinathannair","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.vaccine.2025.127775_bb1370","article-title":"Acute and post-acute COVID-19 cardiovascular complications: a comprehensive review","author":"Kole","year":"2023","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.vaccine.2025.127775_bb1375","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13578-024-01280-y","article-title":"SARS-CoV-2 variants divergently infect and damage cardiomyocytes in vitro and in vivo","volume":"14","author":"Mok","year":"2024","journal-title":"Cell Biosci"},{"key":"10.1016\/j.vaccine.2025.127775_bb1380","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41392-022-01256-9","article-title":"Strong attenuation of SARS-CoV-2 Omicron BA.1 and increased replication of the BA.5 subvariant in human cardiomyocytes","volume":"7","author":"Nchioua","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.vaccine.2025.127775_bb1385","first-page":"797","article-title":"Influenza virus infection in pregnancy: a review","volume":"94","author":"Meijer","year":"2015","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2025.127775_bb1390","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3233\/NPM-15814124","article-title":"Influenza and its treatment during pregnancy: a review","volume":"8","author":"Ghulmiyyah","year":"2015","journal-title":"J Neonatal Perinatal Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb1395","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1055\/s-0036-1586101","article-title":"The effects of influenza vaccination during pregnancy on birth outcomes: a systematic review and meta-analysis","volume":"33","author":"Nunes","year":"2016","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.vaccine.2025.127775_bb1400","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.vaccine.2019.02.019","article-title":"Association between seasonal influenza vaccination with pre- and postnatal outcomes","volume":"37","author":"Getahun","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127775_bb1405","first-page":"9","article-title":"Prenatal immune and endocrine modulators of offspring\u2019s brain development and cognitive functions later in life","author":"Schepanski","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.127775_bb1410","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1001\/jamapsychiatry.2019.0029","article-title":"Long-term Risk of neuropsychiatric disease after exposure to infection in utero","volume":"76","author":"Al-Haddad","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.vaccine.2025.127775_bb1415","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s10803-010-1006-y","article-title":"Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders","volume":"40","author":"Atlad\u00f3ttir","year":"2010","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.vaccine.2025.127775_bb1420","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.5479","article-title":"Attitudes toward COVID-19 vaccines among pregnant and recently pregnant individuals","volume":"7","author":"Williams","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2025.127775_bb1425","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41541-024-00913-0","article-title":"A scoping review of global COVID-19 vaccine hesitancy among pregnant persons","volume":"9","author":"Casubhoy","year":"2024","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2025.127775_bb1430","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41591-021-01666-2","article-title":"SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland","volume":"28","author":"Stock","year":"2022","journal-title":"Nature Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb1435","doi-asserted-by":"crossref","first-page":"830","DOI":"10.15585\/mmwr.mm7338a1","article-title":"COVID-19-associated hospitalizations and maternal vaccination among infants aged <6 months - COVID-NET, 12 states, October 2022-April 2024","volume":"73","author":"Havers","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2025.127775_bb1440","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1001\/jama.2023.26945","article-title":"Neonatal outcomes after COVID-19 vaccination in pregnancy","volume":"331","author":"Norman","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2025.127775_bb1445","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s40264-024-01458-w","article-title":"Safety and effectiveness of COVID-19 vaccines during pregnancy: a living systematic review and meta-analysis","volume":"47","author":"Ciapponi","year":"2024","journal-title":"Drug Saf"},{"key":"10.1016\/j.vaccine.2025.127775_bb1450","first-page":"9","article-title":"Effectiveness and safety of COVID-19 vaccines on maternal and perinatal outcomes: a systematic review and meta-analysis","author":"Fern\u00e1ndez-Garc\u00eda","year":"2024","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.vaccine.2025.127775_bb1455","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1016\/j.vaccine.2024.02.084","article-title":"Safety monitoring of bivalent mRNA COVID-19 vaccine among pregnant persons in the vaccine adverse event reporting system - United States, September 1, 2022 - March 31, 2023","volume":"42","author":"Moro","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127775_bb1460","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-074035","article-title":"Maternal mRNA covid-19 vaccination during pregnancy and delta or omicron infection or hospital admission in infants: test negative design study","volume":"380","author":"Jorgensen","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2025.127775_bb1465","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2204399","article-title":"Maternal vaccination and risk of hospitalization for covid-19 among infants","volume":"387","author":"Halasa","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb1470","doi-asserted-by":"crossref","first-page":"460.e1","DOI":"10.1016\/j.ajog.2024.02.008","article-title":"Maternal vaccination against COVID-19 and neonatal outcomes during omicron: INTERCOVID-2022 study","volume":"231","author":"Barros","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2025.127775_bb1475","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.42475","article-title":"mRNA SARS-CoV-2 vaccination before vs during pregnancy and omicron infection among infants","volume":"6","author":"Goh","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2025.127775_bb1480","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.15585\/mmwr.mm7145a3","article-title":"COVID-19-associated hospitalizations among U.S. infants aged <6 months - COVID-NET, 13 States, June 2021\u2013August 2022","volume":"71","author":"Hamid","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2025.127775_bb1485","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jamainternmed.2022.2442","article-title":"Association of COVID-19 vaccination during pregnancy with incidence of SARS-CoV-2 infection in infants","volume":"182","author":"Carlsen","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb1490","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1146\/annurev-criminol-030521-103146","article-title":"COVID-19 in carceral systems: a review","volume":"6","author":"Puglisi","year":"2023","journal-title":"Annu Rev Criminol"},{"key":"10.1016\/j.vaccine.2025.127775_bb1495","doi-asserted-by":"crossref","first-page":"E946","DOI":"10.1503\/cmaj.201197","article-title":"For-profit long-term care homes and the risk of COVID-19 outbreaks and resident deaths","volume":"192","author":"Stall","year":"2020","journal-title":"CMAJ"},{"key":"10.1016\/j.vaccine.2025.127775_bb1500","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jamainternmed.2020.6466","article-title":"Association between nursing home crowding and COVID-19 infection and mortality in Ontario, Canada","volume":"181","author":"Brown","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2025.127775_bb1505","doi-asserted-by":"crossref","first-page":"S339","DOI":"10.2105\/AJPH.2009.175174","article-title":"Pandemic influenza and jail facilities and populations","volume":"99","author":"Maruschak","year":"2009","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2025.127775_bb1510","author":"Canadian Institute for Health Information"},{"key":"10.1016\/j.vaccine.2025.127775_bb1515","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1186\/s12889-023-16499-6","article-title":"Comorbidities associated with the severity of COVID-19, and differences across ethnic groups: a UK Biobank cohort study","volume":"23","author":"Patel","year":"2023","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2025.127775_bb1520","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1377\/hlthaff.2020.00897","article-title":"COVID-19 and racial\/ethnic disparities in health risk, employment, and household composition","volume":"39","author":"Selden","year":"2020","journal-title":"Health Aff"},{"key":"10.1016\/j.vaccine.2025.127775_bb1525","doi-asserted-by":"crossref","first-page":"E599","DOI":"10.9778\/cmajo.20220031","article-title":"Seropositivity and risk factors for SARS-CoV-2 infection in a South Asian community in Ontario: a cross-sectional analysis of a prospective cohort study","volume":"10","author":"Anand","year":"2022","journal-title":"CMAJ Open"},{"key":"10.1016\/j.vaccine.2025.127775_bb1530","doi-asserted-by":"crossref","DOI":"10.17269\/s41997-024-00885-7","article-title":"Sociodemographic factors associated with vaccine hesitancy in the South Asian community in Canada","author":"Manoharan","year":"2024","journal-title":"Can J Public Health"},{"key":"10.1016\/j.vaccine.2025.127775_bb1535","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.bbi.2022.10.019","article-title":"Socioeconomic and race\/ethnic differences in immunosenescence: evidence from the health and retirement study","volume":"107","author":"Noppert","year":"2023","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.vaccine.2025.127775_bb1540","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.vaccine.2019.01.084","article-title":"Race-related differences in functional antibody response to pneumococcal vaccination in HIV-infected individuals","volume":"37","author":"Happe","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127775_bb1545","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.vaccine.2005.09.058","article-title":"Age-related changes in the immune response to influenza vaccination in a racially diverse, healthy elderly population","volume":"24","author":"Gardner","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127775_bb1550","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1016\/j.vaccine.2022.04.030","article-title":"Overcoming COVID-19 vaccine hesitancy among ethnic minorities: a systematic review of UK studies","volume":"40","author":"Hussain","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127775_bb1555","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1016\/j.vaccine.2011.03.108","article-title":"Trends in US pediatric influenza vaccination from 2006 to 2010 among children with private insurance","volume":"29","author":"Toback","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127775_bb1560","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/cid\/ciy748","article-title":"Early bird gets the flu: what should be done about waning intraseasonal immunity against seasonal influenza?","volume":"68","author":"Rambhia","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb1565","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.amepre.2010.03.010","article-title":"Late-season influenza vaccination: a National Survey of Physician Practice and Barriers","volume":"39","author":"Suh","year":"2010","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb1570","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1001\/jama.2024.7370","article-title":"Combined vaccines against COVID-19, flu, and other respiratory illnesses could soon be available","volume":"331","author":"Rubin","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2025.127775_bb1575","first-page":"1","article-title":"Comparison of healthcare resource use and cost between influenza and COVID-19 vaccine coadministration and influenza vaccination only","author":"Mehta","year":"2024","journal-title":"J Med Econ"},{"key":"10.1016\/j.vaccine.2025.127775_bb1580","first-page":"44","article-title":"Immunogenicity of concomitant SARS-CoV-2 and influenza vaccination in UK healthcare workers: a prospective longitudinal observational study","author":"Nazareth","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.vaccine.2025.127775_bb1585","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S2213-2600(21)00557-9","article-title":"Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged \u226565 years: a phase 2, randomised, open-label study","volume":"10","author":"Izikson","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.vaccine.2025.127775_bb1590","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.42151","article-title":"Estimated effectiveness of coadministration of the BNT162b2 BA.4\/5 COVID-19 vaccine with influenza vaccine","volume":"6","author":"McGrath","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2025.127775_bb1595","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.32813","article-title":"Immunogenicity and reactogenicity of coadministration of COVID-19 and influenza vaccines","volume":"6","author":"Gonen","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2025.127775_bb1600","author":"National Center for Immunization and Respiratory Diseases"},{"key":"10.1016\/j.vaccine.2025.127775_bb1605","doi-asserted-by":"crossref","first-page":"13326","DOI":"10.1038\/s41598-024-64044-1","article-title":"Differential responses of SARS-CoV-2 variants to environmental drivers during their selective sweeps","volume":"14","author":"Smith","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2025.127775_bb1610","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/infdis\/jiab161","article-title":"Coronavirus occurrence in the household influenza vaccine evaluation (HIVE) cohort of Michigan households: reinfection frequency and serologic responses to seasonal and severe acute respiratory syndrome coronaviruses","volume":"224","author":"Petrie","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb1615","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054445","article-title":"Latitudinal variations in seasonal activity of influenza and respiratory syncytial virus (RSV): a global comparative review","volume":"8","author":"Bloom-Feshbach","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2025.127775_bb1620","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.2598","article-title":"Estimation of COVID-19 mRNA vaccine effectiveness and COVID-19 illness and severity by vaccination status during omicron BA.4 and BA.5 sublineage periods","volume":"6","author":"Link-Gelles","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2025.127775_bb1625","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1038\/s41467-024-45549-9","article-title":"Comparing frequency of booster vaccination to prevent severe COVID-19 by risk group in the United States","volume":"15","author":"Park","year":"2024","journal-title":"Nature Comm"},{"key":"10.1016\/j.vaccine.2025.127775_bb1630","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105275","article-title":"First SARS-CoV-2 omicron infection as an effective immune booster among mRNA vaccinated individuals: final results from the first phase of the PRIBIVAC randomised clinical trial","volume":"107","author":"Poh","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.vaccine.2025.127775_bb1635","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijid.2022.05.031","article-title":"Infectivity versus fatality of SARS-CoV-2 mutations and influenza","volume":"121","author":"Xue","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb1640","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-025-03599-6","article-title":"Immune history shapes human antibody responses to H5N1 influenza viruses","author":"Garretson","year":"2025","journal-title":"Nature Med."},{"key":"10.1016\/j.vaccine.2025.127775_bb1645","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1038\/s41467-020-18465-x","article-title":"Middle-aged individuals may be in a perpetual state of H3N2 influenza virus susceptibility","volume":"11","author":"Gouma","year":"2020","journal-title":"Nature Comm"},{"key":"10.1016\/j.vaccine.2025.127775_bb1650","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.05.059","article-title":"High vaccine effectiveness against severe COVID-19 outcomes and population preventable fraction during the Omicron era in Luxembourg: a nationwide retrospective risk factor analysis","volume":"42","author":"Bejko","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127775_bb1655","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106293","article-title":"Protection of vaccine boosters and prior infection against mild\/asymptomatic and moderate COVID-19 infection in the UK SIREN healthcare worker cohort: October 2023 to March 2024","volume":"89","author":"Kirwan","year":"2024","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2025.127775_bb1660","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102148","article-title":"Early Omicron infection is associated with increased reinfection risk in older adults in long-term care and retirement facilities","volume":"63","author":"Breznik","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.vaccine.2025.127775_bb1665","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0140-6736(22)02465-5","article-title":"Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis","volume":"401","author":"COVID-19 Forecasting Team","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.127775_bb1670","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S1473-3099(22)00816-7","article-title":"Humoral immune evasion of the omicron subvariants BQ.1.1 and XBB","volume":"23","author":"Uraki","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127775_bb1675","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2023.105500","article-title":"Severity outcomes associated with SARS-CoV-2 XBB variants, an observational analysis","volume":"165","author":"Klein","year":"2023","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2025.127775_bb1680","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2024.29.7.2400076","article-title":"2023\/24 Mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN)","volume":"29","author":"Skowronski","year":"2024","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2025.127775_bb1685","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2025.2466699","article-title":"Vaccine effectiveness dynamics against influenza and SARS-CoV-2 in community-tested patients in France 2023\u20132024","volume":"14","author":"Abou Chakra","year":"2025","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2025.127775_bb1690","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.puhe.2024.07.010","article-title":"Is COVID-19 finally just a bad flu? Follow-up study comparing disease severity among COVID-19 and seasonal influenza hospital in-patients across pandemic waves in Ireland","volume":"236","author":"O\u2019Farrell","year":"2024","journal-title":"Public Health"},{"key":"10.1016\/j.vaccine.2025.127775_bb1695","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41577-020-00434-6","article-title":"Immunological considerations for COVID-19 vaccine strategies","volume":"20","author":"Jeyanathan","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2025.127775_bb1700","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s44298-024-00043-3","article-title":"Beyond COVID-19: the promise of next-generation coronavirus vaccines","volume":"2","author":"Koolaparambil Mukesh","year":"2024","journal-title":"NPJ Viruses"},{"key":"10.1016\/j.vaccine.2025.127775_bb1705","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/s42003-022-04030-3","article-title":"Dynamic SARS-CoV-2 emergence algorithm for rationally-designed logical next-generation vaccines","volume":"5","author":"Maison","year":"2022","journal-title":"Commun Bio"},{"key":"10.1016\/j.vaccine.2025.127775_bb1710","doi-asserted-by":"crossref","first-page":"6000","DOI":"10.1038\/s41467-025-60726-0","article-title":"Induction of lung mucosal immunity by a next-generation inhaled aerosol COVID-19 vaccine: an open-label, multi-arm phase 1 clinical trial","volume":"16","author":"Jeyanathan","year":"2025","journal-title":"Nature Comm"},{"key":"10.1016\/j.vaccine.2025.127775_bb1715","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127602","article-title":"Mucosal COVID-19 vaccines in clinical development","volume":"63","author":"Tscherne","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127775_bb1720","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41573-024-01042-y","article-title":"mRNA vaccines for infectious diseases \u2014 advances, challenges and opportunities","volume":"23","author":"Pardi","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.vaccine.2025.127775_bb1725","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2024.29.15.2400178","article-title":"Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024","volume":"29","author":"N\u00f8rgaard","year":"2024","journal-title":"Euro Surveill"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25010722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25010722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T07:38:37Z","timestamp":1765870717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25010722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":345,"alternative-id":["S0264410X25010722"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127775","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationalizing recommendations for influenza and COVID-19 vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127775","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127775"}}